Title : LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer.

Pub. Date : 2017 Feb 7

PMID : 27999210






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer. LY3009120 B-Raf proto-oncogene, serine/threonine kinase Homo sapiens